Moran Susan 4
4 · RayzeBio, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
RayzeBio, Inc.RYZB
Moran Susan
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-01-22$3.24/sh+30,875$100,035→ 322,647 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-01-22−30,875→ 60,757 totalExercise: $3.24Exp: 2031-09-28→ Common Stock (30,875 underlying)
Footnotes (1)
- [F1]The option is subject to an early exercise provision and is immediately exercisable. 25% of the shares vested on September 29, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.